Lv1
70 积分 2024-09-06 加入
Can Neutrophil‐to‐Lymphocyte Ratio, Monocyte‐to‐Lymphocyte Ratio, and Platelet‐to‐Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
5小时前
已完结
Neutrophil to lymphocyte ratio (NLR) impact on the progression-free survival and overall survival of multiple myeloma patients treated with high-dose chemotherapy and autologous stem cell transplantation
6小时前
待确认
IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma
20天前
已完结
Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
3个月前
已完结
Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice
6个月前
已完结
Potential future direction of measurable residual disease evaluation in multiple myeloma
6个月前
已关闭
Potential future direction of measurable residual disease evaluation in multiple myeloma
6个月前
已关闭
Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice
6个月前
已完结
Diagnosis and Management of Multiple Myeloma
6个月前
已完结
How I manage mantle cell lymphoma: indolent versus aggressive disease
7个月前
已完结
皖公网安备34019202002308
